Company

Reverse Ionizer, LLC (RI) has developed patented revolutionary water treatment technology that it plans to license to strategic manufacturing and sales partners beginning in 2025, which will provide building and facility owners more reliable, cost-effective and less risky methods of water treatment, compared to what has been available at any time.

RI has now successfully completed laboratory testing and initial field trials of its Plasma Disinfection System (PDS) technology, that have demonstrated to effectively mitigate pathogens (Legionella and other bacteria, viruses and parasites) in cooling tower simulations.

A field pilot program is currently underway at a Fortune 200 company's world headquarters campus. Preliminary test results are indicating the PDS has reduced live legionella bacteria at sustained levels below 10 colony forming units (CFU) per milliliter (ml) of water (the regulatory target of many states).

Concurrently, RI is now seeking manufacturing and service partner relationships with an objective of market introduction in early 2025.

RI’s breakthrough PDS technology combines two proven water treatment methods with advanced non-thermal plasma designed to provide a ‘continuous kill’ or control of the growth of pathogens in water systems, which can be inhaled through the evaporative aerosol drift of most cooling towers. Early testing has already shown that if a virus is waterborne, RI's PDS has the potential to destroy any virus, including COVID-19.

RI also has undertaken significant research to develop a disruptive radio frequency-based electromagnetic (ExB) technology that reverses the polarity of scaling ions in cooling towers and mitigates scale and corrosion, which can significantly reduce the life of cooling towers thereby reducing their efficiencies in energy and water usage.

RI's proprietary technology can be used in many commercial or industrial applications, and will initially be targeted for deployment in United States and then internationally, with desalination being among the first application for RI's ExB probe.